BioGend – RevoCart Cartilage Repair and Regeneration Technology
BioGend’s One-Step Autologous Cartilage Repair System, RevoCart, is a cartilage repair procedure and a milestone for knee cartilage surgery. As exercise gains more popularity and society continues to age, the number of people suffering from degenerative arthritis and sports-related joint injuries has been increasing. With a one-step minimally invasive procedure, this technology has assisted many patients in successful autologous knee cartilage repair.
The One-Step Autologous Cartilage Repair System was developed based on the Biphasic Cartilage Repair Implant (BiCRI) technology, a collaborative result produced by ITRI and National Taiwan University Hospital (NTUH) years ago. The technology was then transferred to Exactech Taiwan, which was later acquired by BioGend. Based on this technology, BioGend created the One-Step Autologous Cartilage Repair System RevoCart®.
Benefits and Applications
RevoCart® helps osteochondral tissues to heal and is thus suitable for the repair of chondral or osteochondral defects in the medial and lateral femoral epicondyles of the knee joint and femoral trochlea. The technology can avoid the issues caused by autologous cartilage regeneration repair techniques, such as infection and pain at the harvest site that will lead to longer recovery periods. It can also address the problem of insufficient bone volume. What’s better, RevoCart® requires only a single minimally invasive surgery that takes about one hour and eliminates the need for in vitro cell cultures. This significantly saves valuable healthcare resources and reduces hospitalization costs while reducing pain for patients.
#chondral lesion
# osteochondral lesion
# OCD
# osteochondritis dissecans
# OA
# Osteoarthritis
